Cargando…
Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
BACKGROUND: Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic adult-onset primary tauopathies clinically classified among the atypical parkinsonian syndromes. They are intrinsically related with regard to their clinical features, pathology, biochemistry, and genet...
Autores principales: | Parmera, Jacy Bezerra, de Oliveira, Marcos Castello Barbosa, Rodrigues, Roberta Diehl, Coutinho, Artur Martins |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academia Brasileira de Neurologia - ABNEURO
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491415/ https://www.ncbi.nlm.nih.gov/pubmed/35976324 http://dx.doi.org/10.1590/0004-282X-ANP-2022-S134 |
Ejemplares similares
-
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options
por: Lamb, Ruth, et al.
Publicado: (2016) -
Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review
por: Otani, Rafael Tomio Vicentini, et al.
Publicado: (2022) -
Corticobasal syndrome: A diagnostic conundrum
por: Parmera, Jacy Bezerra, et al.
Publicado: (2016) -
Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2020) -
Language impairment in progressive supranuclear palsy and corticobasal syndrome
por: Peterson, Katie A., et al.
Publicado: (2019)